Angeles Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Angeles Investment Advisors's PFE Position: Q1 2025 in Review
Angeles Investment Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 16,507 shares — an estimated $438K sold.
Angeles Investment Advisors first reported a position in PFE in Q3 2019 and held it in 16 quarters. The position peaked at $968K in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Angeles Investment Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Angeles Investment Advisors sold 16,507 Pfizer shares in Q1 2025, an estimated $438K.
- Angeles Investment Advisors first reported a position in Pfizer in Q3 2019 and held it in 16 quarters.
- Angeles Investment Advisors's Pfizer position peaked at $968K in Q4 2021.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Angeles Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.